awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33670385-52C16BA0-AF31-452E-AC4C-0FFE608AB53C
Q33670385-52C16BA0-AF31-452E-AC4C-0FFE608AB53C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33670385-52C16BA0-AF31-452E-AC4C-0FFE608AB53C
Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major.
P2860
Q33670385-52C16BA0-AF31-452E-AC4C-0FFE608AB53C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33670385-52C16BA0-AF31-452E-AC4C-0FFE608AB53C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a4d6d93797a9e621b28c94750ea53a0b82d1e5f3
P2860
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.